Go HemMobileTM

HemMobileTM is a free app that lets you keep track of your infusions and any bleeds you might have. This information may be helpful to share with your doctor at your next appointment.

  • Download now
  • Available on the App Store
  • google-play

hemmobile-phone

BeneFIX® Coagulation Factor IX (Recombinant) Safety Info | Hemophilia B Treatment

Send to a friend

 

Oops! We've encountered an error.

Click here to try again.

 

Cancel X Benefix

Continue

What Is BeneFix?

BeneFix® Coagulation Factor IX (Recombinant) is an injectable medicine that is used to help control and prevent bleeding in people with hemophilia B. Hemophilia B is also called congenital factor IX deficiency or Christmas disease.

BeneFix is NOT used to treat hemophilia A.

Important Safety Information for BeneFix

  • BeneFix is contraindicated in patients who have manifested life-threatening, immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including hamster protein.

  • Call your health care provider right away if your bleeding is not controlled after using BeneFix.

  • Allergic reactions may occur with BeneFix. Call your health care provider or get emergency treatment right away if you have any of the following symptoms: wheezing, difficulty breathing, chest tightness, your lips and gums turning blue, fast heartbeat, facial swelling, faintness, rash or hives.

  • Your body can make antibodies, called "inhibitors," which may interfere with the effectiveness of BeneFix.

  • If you have risk factors for developing blood clots, such as a venous catheter through which BeneFix is given by continuous infusion, BeneFix may increase the risk of abnormal blood clots. The safety and efficacy of BeneFix administration by continuous infusion have not been established.

  • Some common side effects of BeneFix are nausea, injection site reaction, injection site pain, headache, dizziness and rash.

Please see full Prescribing Information for BeneFix.

SCROLL FOR IMPORTANT SAFETY INFORMATION AND INDICATION